108 related articles for article (PubMed ID: 30605956)
21. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
Woo KT; Lau YK; Wong KS; Chiang GS
Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
[TBL] [Abstract][Full Text] [Related]
22. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
[TBL] [Abstract][Full Text] [Related]
23. Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.
Brakemeier S; Bachmann F; Budde K
Pediatr Nephrol; 2017 Jul; 32(7):1137-1144. PubMed ID: 27585680
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Use-Long-term Follow-up of First Tuberous Sclerosis Complex Patient Treated De Novo With Sirolimus After Kidney Transplantation: A Case Report.
Tarasewicz A; Dębska-Ślizień A; Rutkowska B; Szurowska E; Matuszewski M
Transplant Proc; 2018; 50(6):1904-1909. PubMed ID: 30056926
[TBL] [Abstract][Full Text] [Related]
25. APOL1 channel blocker reduces proteinuria in FSGS.
Olabisi OA
Kidney Int; 2023 Aug; 104(2):228-230. PubMed ID: 37224918
[No Abstract] [Full Text] [Related]
26. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
Packham DK; Yan HD; Hewitson TD; Nicholls KM; Fairley KF; Kincaid-Smith P; Becker GJ
Clin Nephrol; 1996 Oct; 46(4):225-9. PubMed ID: 8905206
[TBL] [Abstract][Full Text] [Related]
27. Tuberous sclerosis complex: advances in diagnosis, genetics, and management.
Schwartz RA; Fernández G; Kotulska K; Jóźwiak S
J Am Acad Dermatol; 2007 Aug; 57(2):189-202. PubMed ID: 17637444
[TBL] [Abstract][Full Text] [Related]
28. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
[TBL] [Abstract][Full Text] [Related]
29. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
Gao R; Wu W; Wen Y; Li X
Int Urol Nephrol; 2017 Jul; 49(7):1233-1241. PubMed ID: 28349446
[TBL] [Abstract][Full Text] [Related]
30. Angiomyolipomas, renal manifestation of tuberous sclerosis complex in 17-year-old boy--a case report.
Brodkiewicz A; Marciniak H; Szychot E; Walecka A; Peregud-Pogorzelski J
Ann Acad Med Stetin; 2008; 54(2):160-5. PubMed ID: 19374247
[TBL] [Abstract][Full Text] [Related]
31. Sirolimus for Retinal Astrocytic Hamartoma Associated with Tuberous Sclerosis Complex.
Zhang ZQ; Shen C; Long Q; Yang ZK; Dai RP; Wang J; Zhang W; Pan Q; Zhu Z; Xu KF
Ophthalmology; 2015 Sep; 122(9):1947-9. PubMed ID: 25912145
[No Abstract] [Full Text] [Related]
32. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
[TBL] [Abstract][Full Text] [Related]
33. Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease.
Lee YJ; Cho S; Kim SR; Jang HR; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
Postgrad Med J; 2011 Oct; 87(1032):664-9. PubMed ID: 21715572
[TBL] [Abstract][Full Text] [Related]
34. [Nephrotic syndrome in a woman with tuberous sclerosis].
Sauter M; Berger F; Fischereder M
Dtsch Med Wochenschr; 2014 May; 139(20):1046-50. PubMed ID: 24801299
[TBL] [Abstract][Full Text] [Related]
35. Segmental tuberous sclerosis in a patient presenting as unilateral facial angiofibromas, periungual fibromas and Shagreen patch.
Sener S; Sasmaz S
Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):980-2. PubMed ID: 21845812
[TBL] [Abstract][Full Text] [Related]
36. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
37. Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an experimental nephrotic syndrome model.
Yilmaz MI; Korkmaz A; Kaya A; Sonmez A; Caglar K; Topal T; Eyileten T; Yenicesu M; Acikel C; Oter S; Yaman H; Aktug H; Oguz Y; Vural A; Ikizler TA
Nephron Exp Nephrol; 2006; 104(1):e15-22. PubMed ID: 16699289
[TBL] [Abstract][Full Text] [Related]
38. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
[TBL] [Abstract][Full Text] [Related]
39. The ominous sequence in patients with tuberous sclerosis complex.
Yamada H; Akiyoshi K; Izumi T
Brain Dev; 2014 Mar; 36(3):254-8. PubMed ID: 23647917
[TBL] [Abstract][Full Text] [Related]
40. Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.
Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Berkowitz N; Miao S; Segal S; Peyrard S; Budde K
Nephrol Dial Transplant; 2016 Jan; 31(1):111-9. PubMed ID: 26156073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]